Resistell AG closes CHF 3.5M series A financing round

We invite you to meet us in Berlin at Novel Antimicrobials & AMR Diagnostics Conference (14-15.03.2019). For more details please visit https://amr-conference.com

The jury of industry experts and investors selected Resistell to receive the highest level of Venture Kick’s financial support to bring their businesses to market.

Resistell has closed an oversubscribed seed financing round. Lead Investor Occident Group AG, Hemex AG and six other private investors invested in the EPFL spin-off developing the world’s fastest phenotypic antibiotic susceptibility test.

Resistell AG a finalist of the Swiss Technology Award 2018!

Resistell wins the MassChallenge Switzerland 2018 Gold Award

Warning comes as report shows 3 million common surgical procedures could be hazardous if infections become resistant to antibiotics

Join us at the annual meeting of the Swiss Society for Microbiology held within the CHUV, Lausanne.